Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies, including masked T cell ...

Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies, including masked T cell engagers, with $52.0 million in upfront payments Extended ant ...

Collaboration will combine AbbVie’s oncology expertise and Xilio’s proprietary tumor-activation technology to develop novel immunotherapies, ...

ORLADEYO ® (berotralstat) is the first and only oral therapy designed specifically to prevent attacks of hereditary ...

A leading fund manager expects more strong performance from this surging ASX 200 healthcare stock. The post Up 135% in a year ...

Children may have a higher risk of developing ADHD if their mothers used paracetamol – also known as acetaminophen – during ...

Outperformance during the fourth quarter primarily resulted from stock selection and an overweight in industrials. Read more ...

Researchers are delving deeper into the role of leukocyte telomere length as it relates to stroke, dementia, and depression ...

A consistent safety profile and sustained efficacy were observed in patients with moderate to severe plaque psoriasis.

We recently published a list of 10 Best Nasdaq Stocks Under $5 to Buy. In this article, we are going to take a look at where ...